The endTB-Q clinical trial results will be presented at the Union Conference in Bali

We are happy to announce that the endTB-Q clinical trial results will be presented for the first time at the Union World Conference on Lung Health, in Bali, Indonesia, November 12-16. You can find the details about the session below. Join us at the conference! 

Presentation title: endTB-Q: Interim results of a randomised controlled trial testing a shorter treatment strategy for pre-XDR TB

Session title: The Union-CDC late-breaker session (treatment and clinical trials)

Date: November 13

Time: 16:10-17:40

Room: Mangupura

The endTB team looks forward to other important presentations related to the endTB project at the Union Conference: 

• Nov 13, 11:10 : Access to lifesaving medicines for lung health​ in the Opening plenary, Christophe Perrin, Access Campaign
• Nov 13, 17:00: Acquisition of resistance to bedaquiline, delamanid, clofazimine, linezolid, and fluoroquinolones during treatment in the endTB trial​ in The Union-CDC late-breaker session (treatment and clinical trials), Elisa Ardizzoni, ITM​
• Nov 15, 9:20: Sympo SP17​: Bridging the Gap from Policy to Practice for Effective and Ethical Integration of New Shorter MDR/RR-TB Regimens
• Nov 15​, 14:20: Sympo SP21​: Mitigating bias and improving inference from observational studies and clinical trials of MDR/RR-TB treatment and diagnostics
• Nov 16, 09:30: Investigating heteroresistance in M. tuberculosis: findings from the endTB trial Oral Abstract session 49 on Filling in the TB knowledge gaps: Research in action from new drugs to operational research, Bouke De Jong, ITM​

More details on the conference programme and registration here: https://conf2024.theunion.org/.